Trends in post osteoporotic hip fracture care from 2010 to 2014 in a private hospital in Malaysia.
10.1016/j.afos.2017.05.001
- Author:
Swan Sim YEAP
1
;
M F R NUR FAZIRAH
;
C NUR AISYAH
;
Siti Yazmin Zahari SHAM
;
Intan Nureslyna SAMSUDIN
;
Subashini C THAMBIAH
;
Fen Lee HEW
;
Boon Ping LIM
;
Yew Siong SIOW
;
Siew Pheng CHAN
Author Information
1. Department of Medicine, Subang Jaya Medical Centre, Subang Jaya, Selangor, Malaysia. swanyeap@gmail.com
- Publication Type:Original Article
- Keywords:
Audit;
Osteoporosis;
Hip fractures;
Treatment;
Malaysia
- MeSH:
Arthritis;
Bone Density;
Hip Fractures;
Hip*;
Hospitals, Private*;
Humans;
Malaysia*;
Osteoporosis;
Osteoporotic Fractures
- From:Osteoporosis and Sarcopenia
2017;3(2):112-116
- CountryRepublic of Korea
- Language:English
-
Abstract:
OBJECTIVE: Following an osteoporotic fracture, pharmacological treatment is recommended to increase bone mineral density and prevent future fractures. However, the rate of starting treatment after an osteoporotic hip fracture remains low. The objective of this study was to survey the treatment rate following a low-trauma hip fracture at a tertiary private hospital in Malaysia over a period of 5 years. METHODS: The computerised hospital discharge records were searched using the terms “hip,”“femur,”“femoral,”“trochanteric,”“fracture,” or “total hip replacement” for all patients over the age of 50, admitted between 2010 and 2014. The medical charts were obtained and manually searched for demographic data and treatment information. Hip operations done for non–low-trauma-related fracture and arthritis were excluded. RESULTS: Three hundred seventy patients over the age of 50 years were admitted with a hip fracture, of which 258 (69.7%) were low trauma, presumed osteoporotic, hip fractures. The median age was 79.0 years (interquartile range [IQR], 12.0). Following a hip fracture, 36.8% (95 of 258) of the patients received treatment, but out of these, 24.2% (23 of 95) were on calcium/vitamin D only. The median duration of treatment was 1 month (IQR, 2.5). In 2010, 56.7% of the patients received treatment, significantly more than subsequent years 2011–2014, where approximately only 30% received treatment. CONCLUSIONS: Following a low-trauma hip fracture, approximately 72% of patients were not started on active antiosteoporosis therapy. Of those who were, the median duration of treatment was 1 month. This represents a missed opportunity for the prevention of future fractures.
